Related references
Note: Only part of the references are listed.The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh et al.
ANNALS OF SURGERY (2019)
Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann et al.
CANCERS (2019)
Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Oonagh M. Griffin et al.
PANCREATOLOGY (2019)
The Role of the Small Bowel in Unintentional Weight Loss after Treatment of Upper Gastrointestinal Cancers
Babak Dehestani et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer
Ana Babic et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Progressive Resistance Training to Impact Physical Fitness and Body Weight in Pancreatic Cancer Patients A Randomized Controlled Trial
Joachim Wiskemann et al.
PANCREAS (2019)
Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy
Jordan M. Cloyd et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Essential role of radiation therapy for the treatment of pancreatic cancer
Sophie Dobiasch et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
A comparison of three methods to assess body composition
Nilanjana Tewari et al.
NUTRITION (2018)
Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
Cynthia Stretch et al.
PLOS ONE (2018)
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer
Marta Sandini et al.
JAMA SURGERY (2018)
Altered exocrine function can drive adipose wasting in early pancreatic cancer
Laura V. Danai et al.
NATURE (2018)
Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis
Ioannis Mintziras et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes
Ya-Chin Hou et al.
JOURNAL OF CLINICAL MEDICINE (2018)
TNF-α and cancer cachexia: Molecular insights and clinical implications
Hetal J. Patel et al.
LIFE SCIENCES (2017)
Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions
Laura Nemer et al.
PANCREAS (2017)
Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning
Ahmed M. Zaky et al.
RADIOGRAPHICS (2017)
A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer
Daniel Delitto et al.
SURGERY (2017)
Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study
Go Ninomiya et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
Preoperative sarcopenia determinants in pancreatic cancer patients
Giulia Carrara et al.
CLINICAL NUTRITION (2017)
Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer
Shinya Okumura et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
S. Schwarz et al.
BMC CANCER (2017)
Pancreatic Cancer Surgery The New R-status Counts
Oliver Strobel et al.
ANNALS OF SURGERY (2017)
Locally Advanced Pancreatic Cancer Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients
Thilo Hackert et al.
ANNALS OF SURGERY (2016)
Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer
George Malietzis et al.
ANNALS OF SURGERY (2016)
The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma
Katie E. Rollins et al.
CLINICAL NUTRITION (2016)
A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer
Marta Sandini et al.
NUTRITION (2016)
Understanding cachexia as a cancer metabolism syndrome
P. E. Porporato
ONCOGENESIS (2016)
What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults?
Lisa Schweitzer et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review
Ozola Zalite et al.
PANCREATOLOGY (2015)
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer
Amanda B. Cooper et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
Younak Choi et al.
PLOS ONE (2015)
Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model-a study based on data from an international multicentre project (EPCRC-CSA)
D. Blum et al.
ANNALS OF ONCOLOGY (2014)
Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
Stephanie E. Combs et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
Carla M. Prado et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Understanding the mechanisms and treatment options in cancer cachexia
Kenneth Fearon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Cachexia in Patients with Chronic Pancreatitis and Pancreatic Cancer: Impact on Survival and Outcome
Jeannine Bachmann et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2013)
Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single Institution
Joo Kyung Park et al.
PLOS ONE (2013)
Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer
P. Naumann et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2013)
Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
Sebastien Gaujoux et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis
A. Shuster et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
Daniel Habermehl et al.
RADIATION ONCOLOGY (2012)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Intra-abdominal Fat Predicts Survival in Pancreatic Cancer
Courtney J. Balentine et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion
Shuichi Mitsunaga et al.
PANCREAS (2008)
Share Paper
